4.7 C
New York
Saturday, February 24, 2024

A second coronavirus vaccine developed in India is set to enter phase three clinical trial ‘very, very soon’

  • Cadila Healthcare, also known as Zydus Cadila, is about to start a phase three clinical trial for a potential coronavirus vaccine on roughly 30,000 volunteers, chairman Pankaj Patel told CNBC.
  • The study, which is expected to begin soon, will take about three to three-and-a-half months to complete.
  • India's drugs regulator has already approved the restricted use of two coronavirus vaccines in emergency situations, including one developed locally by Bharat Biotech in collaboration with the state-run Indian Council of Medical Research.

Related Articles

Latest Articles